Back to Search
Start Over
Sildenafil improves the beneficial hemodynamic effects exerted by atorvastatin during acute pulmonary thromboembolism.
- Source :
-
European journal of pharmacology [Eur J Pharmacol] 2011 Nov 30; Vol. 670 (2-3), pp. 554-60. Date of Electronic Publication: 2011 Sep 21. - Publication Year :
- 2011
-
Abstract
- We investigated whether atorvastatin has beneficial hemodynamic effects during acute pulmonary thromboembolism (APT) and whether sildenafil improves these effects. We studied the involvement of oxidative stress, matrix metalloproteinases (MMPs), and neutrophil activation. APT was induced with autologous blood clots (500 mg/kg) in anesthetized male lambs pretreated with atorvastatin (10 mg/kg/day, subcutaneously; 1 week) or vehicle (dimethyl sulfoxide 10% subcutaneously). Sildenafil (0.7 mg/kg intravenously) or saline infusions were performed 60 min after APT induction. Non-embolized control animals received saline. APT significantly increased pulmonary vascular resistance index (PVRI) and mean pulmonary artery pressure (MPAP) by approximately 310% and 258% respectively. While atorvastatin pretreatment attenuated these increases (~150% and 153%, respectively; P < 0.05), its combination with sildenafil was associated with lower increases in PVRI and MPAP (~32% and 36%, respectively). Gelatin zymography showed increased MMP-9 and MMP-2 levels in the bronchoalveolar lavage, and increased MMP-9 levels in plasma from embolized animals. Atorvastatin pretreatment attenuated bronchoalveolar lavage MMP-2 increases. The combination of drugs blunted the MMPs increases in bronchoalveolar lavage and plasma (P < 0.05). Neutrophils accumulated in bronchoalveolar lavage after APT, and atorvastatin pretreatment combined with sildenafil (but not atorvastatin alone) attenuated this effect (P < 0.05). APT increased lung lipid peroxidation and total protein concentrations in bronchoalveolar lavage, thus indicating oxidative stress and alveolar-capillary barrier damage, respectively. Both increases were attenuated by atorvastatin pretreatment alone or combined with sildenafil (P < 0.05). We conclude that pretreatment with atorvastatin protects against the pulmonary hypertension associated with APT and that sildenafil improves this response. These findings may reflect antioxidant effects and inhibited neutrophils/MMPs activation.<br /> (Copyright © 2011 Elsevier B.V. All rights reserved.)
- Subjects :
- Acute Disease
Animals
Atorvastatin
Bronchoalveolar Lavage
Drug Synergism
Enzyme Activation drug effects
Heart Ventricles pathology
Lipid Peroxidation drug effects
Lung drug effects
Lung metabolism
Male
Matrix Metalloproteinases blood
Matrix Metalloproteinases metabolism
Myocytes, Cardiac drug effects
Myocytes, Cardiac metabolism
Neutrophils cytology
Neutrophils drug effects
Oxidative Stress drug effects
Pulmonary Embolism blood
Pulmonary Embolism immunology
Pulmonary Embolism metabolism
Purines pharmacology
Sildenafil Citrate
Hemodynamics drug effects
Heptanoic Acids pharmacology
Piperazines pharmacology
Pulmonary Embolism physiopathology
Pyrroles pharmacology
Sulfones pharmacology
Subjects
Details
- Language :
- English
- ISSN :
- 1879-0712
- Volume :
- 670
- Issue :
- 2-3
- Database :
- MEDLINE
- Journal :
- European journal of pharmacology
- Publication Type :
- Academic Journal
- Accession number :
- 21946107
- Full Text :
- https://doi.org/10.1016/j.ejphar.2011.09.018